Skip to main content
Fig. 3 | BMC Cancer

Fig. 3

From: Quantification of m6A RNA methylation modulators pattern was a potential biomarker for prognosis and associated with tumor immune microenvironment of pancreatic adenocarcinoma

Fig. 3

Relationship between m6A risk score and OS of PAAD patients. A landscape of risk grouped by risk score. B Survival analyses for low and high m6Ascore patient groups using Kaplan-Meier curves. C Time-dependent ROC analysis of risk score in predicting prognoses. D The difference of clinical features between high and low risk group

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us